|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0003241,
umls-concept:C0003873,
umls-concept:C0004083,
umls-concept:C0022417,
umls-concept:C0033684,
umls-concept:C0035448,
umls-concept:C0080103,
umls-concept:C0087111,
umls-concept:C0449258,
umls-concept:C0679199,
umls-concept:C1415576,
umls-concept:C1883709
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2008-5-27
|
|
pubmed:abstractText |
To determine the association of HLA-DRB1, rheumatoid factor (RF), and anti-citrullinated protein antibody (ACPA) status with progression of joint damage in early rheumatoid arthritis (RA) treated according to different treatment strategies.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal,
http://linkedlifedata.com/resource/pubmed/chemical/Antirheumatic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Autoantibodies,
http://linkedlifedata.com/resource/pubmed/chemical/HLA-DR Antigens,
http://linkedlifedata.com/resource/pubmed/chemical/HLA-DRB1 Chains,
http://linkedlifedata.com/resource/pubmed/chemical/Membrane Transport Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Methotrexate,
http://linkedlifedata.com/resource/pubmed/chemical/Mitochondrial Membrane Transport...,
http://linkedlifedata.com/resource/pubmed/chemical/Mitochondrial Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Rheumatoid Factor,
http://linkedlifedata.com/resource/pubmed/chemical/SLC25A13 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Sulfasalazine,
http://linkedlifedata.com/resource/pubmed/chemical/infliximab
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0004-3591
|
|
pubmed:author |
pubmed-author:AllaartC FCF,
pubmed-author:BreedveldF CFC,
pubmed-author:DijkmansB A CBA,
pubmed-author:EwalsJ A P MJA,
pubmed-author:Goekoop-RuitermanY P MYP,
pubmed-author:HuizingaT W JTW,
pubmed-author:KerstensP J S MPJ,
pubmed-author:RondayH KHK,
pubmed-author:SchreuderG M TGM,
pubmed-author:TerwielJ PJP,
pubmed-author:ToesR E MRE,
pubmed-author:VerpoortK NKN,
pubmed-author:de Vries-BouwstraJ KJK,
pubmed-author:de VriesR R PRR
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
58
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1293-8
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:18438829-Adult,
pubmed-meshheading:18438829-Aged,
pubmed-meshheading:18438829-Antibodies, Monoclonal,
pubmed-meshheading:18438829-Antirheumatic Agents,
pubmed-meshheading:18438829-Arthritis, Rheumatoid,
pubmed-meshheading:18438829-Autoantibodies,
pubmed-meshheading:18438829-Disease Progression,
pubmed-meshheading:18438829-Female,
pubmed-meshheading:18438829-HLA-DR Antigens,
pubmed-meshheading:18438829-HLA-DRB1 Chains,
pubmed-meshheading:18438829-Humans,
pubmed-meshheading:18438829-Male,
pubmed-meshheading:18438829-Membrane Transport Proteins,
pubmed-meshheading:18438829-Methotrexate,
pubmed-meshheading:18438829-Middle Aged,
pubmed-meshheading:18438829-Mitochondrial Membrane Transport Proteins,
pubmed-meshheading:18438829-Mitochondrial Proteins,
pubmed-meshheading:18438829-Rheumatoid Factor,
pubmed-meshheading:18438829-Sulfasalazine
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Progression of joint damage in early rheumatoid arthritis: association with HLA-DRB1, rheumatoid factor, and anti-citrullinated protein antibodies in relation to different treatment strategies.
|
|
pubmed:affiliation |
VU University Medical Center, Amsterdam, The Netherlands. jeskadvb@xs4all.nl
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
